Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma.
about
Correlations between selected tumor markers and fluorodeoxyglucose maximal standardized uptake values in esophageal cancerThe effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.Overexpression of OLC1 promotes tumorigenesis of human esophageal squamous cell carcinomaAssociation of angiogenic factors with prognosis in esophageal cancer.Clinical implications of angiogenesis in cancers.Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor levelPredictive and prognostic molecular markers in outcome of esophageal cancer.Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy.Clinical biomarkers of angiogenesis inhibition.Cytokines association with clinical and pathological changes in esophageal squamous cell carcinoma.Molecular alterations and clinical relevance in esophageal squamous cell carcinoma.Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus.AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma.Response to chemoradiatiotherapy in squamous cell carcinoma of the esophagus: evaluation of some prognostic factors.microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma.Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy.Immunohistochemical evaluation for P53 and VEGF (Vascular Endothelial Growth Factor) is not prognostic for long term survival in end stage esophageal adenocarcinoma.Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study.Apparent diffusion coefficient correlation with oesophageal tumour stroma and angiogenesis.Soluble interleukin-6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapy.Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy.Impact of serum biomarkers on esophageal squamous cell carcinomaThe crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy
P2860
Q30436049-291EC4FF-DA53-4A1E-8CA4-57BACDA8FEE8Q33372962-13C5B0A4-CFE3-414D-BF3F-C13F3C2E8179Q34135956-B3B2F51B-0E45-4DF7-ACDA-5EFBE0A92B5FQ35037270-F48AA642-14F3-4A18-A52A-F43BA0B96AE0Q35114578-C01DECF0-9AD5-4602-8807-F51C9BDA8A9BQ35185524-C35409C2-8132-49AB-94BA-53143CCC4FC0Q36012979-ED55837F-68A4-4DD8-A349-6598444FAF90Q36065624-691C06EF-B58F-4891-B4F8-08F961277568Q36636695-FEDACCF1-343B-470D-96EF-80E80AADDE84Q36648089-46B9E1B6-E7A9-400D-9EE7-CEF20CAA2420Q37139413-32AE5FAB-D971-4D88-8282-E4646B28AA9CQ37424186-CD99E985-33DC-4887-A8F1-D192EFDA2E03Q38134029-C3C578E7-7060-4E9D-9CB9-61970ADA0E93Q38878023-B2F3CABA-0184-4BB3-B0FD-E4B14FDD73ABQ41910456-0BFBD3AC-E60B-4A20-8343-033910ECE184Q42174415-EC467D47-2D36-4AA6-A785-6DF9CA2CDF91Q44056340-F4F82578-E828-45E5-B1B2-88844AEA76E7Q44644595-DA5584EE-39E6-427C-8435-362DB4F2EF22Q44781751-D7123122-D53C-40DE-9E9E-18F1616F6079Q47160108-D19F24CF-D393-4C73-B3C9-7CEEA50AED93Q50260035-F6A42076-40E8-49FB-817A-8F7658D03C0AQ51016697-396576A3-FF20-4666-82AA-AAD35945B1A8Q53172824-BDB75EA8-5FB7-48FF-8F98-B52DB934026BQ57707731-7E5BC9E9-1516-4B07-885B-F95F03CAABD6Q58736799-ED059EFC-1C90-4EED-8EDD-70BF03C77D7C
P2860
Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Clinical significance of serum ...... ageal squamous cell carcinoma.
@en
Clinical significance of serum ...... ageal squamous cell carcinoma.
@nl
type
label
Clinical significance of serum ...... ageal squamous cell carcinoma.
@en
Clinical significance of serum ...... ageal squamous cell carcinoma.
@nl
prefLabel
Clinical significance of serum ...... ageal squamous cell carcinoma.
@en
Clinical significance of serum ...... ageal squamous cell carcinoma.
@nl
P2093
P2860
P1433
P1476
Clinical significance of serum ...... ageal squamous cell carcinoma.
@en
P2093
Kobayashi S
Matsubara H
Okazumi SI
P2860
P304
P356
10.1002/1097-0142(20010801)92:3<663::AID-CNCR1368>3.0.CO;2-L
P407
P577
2001-08-01T00:00:00Z